| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 黄芪生脉饮(元) | 205,736,126.82 | 115,282,198.70 | 270,703,244.73 | 134,441,604.31 |
| 伸筋丹胶囊(元) | 22,932,737.78 | 11,213,981.78 | 26,901,312.63 | 12,547,656.31 |
| 西洋参口服液(元) | 33,608,770.07 | 17,791,588.07 | 46,702,441.21 | 20,837,110.57 |
| 其他主营业务(元) | - | - | - | 2,582,910.57 |
| 其他业务(元) | - | - | - | 54,843.07 |
| 其他(元) | 8,007,228.19 | 4,696,161.47 | 7,065,289.44 | 2,582,910.57 |
| 营业成本(元) | ||||
| 黄芪生脉饮(元) | 115,709,896.24 | 56,667,733.82 | 118,046,957.44 | 54,599,006.73 |
| 伸筋丹胶囊(元) | 14,023,952.40 | 6,871,555.90 | 16,353,588.07 | 7,851,545.58 |
| 西洋参口服液(元) | 21,233,029.81 | 11,104,998.27 | 26,651,201.01 | 12,126,748.26 |
| 其他主营业务(元) | - | - | - | 2,969,019.92 |
| 其他业务(元) | - | - | - | 88,347.07 |
| 其他(元) | 7,657,297.78 | 4,381,699.25 | 7,996,346.19 | 2,969,019.92 |
| 毛利(元) | ||||
| 黄芪生脉饮(元) | 90,026,230.58 | 58,614,464.88 | 152,656,287.29 | 79,842,597.58 |
| 伸筋丹胶囊(元) | 8,908,785.38 | 4,342,425.88 | 10,547,724.56 | 4,696,110.73 |
| 西洋参口服液(元) | 12,375,740.26 | 6,686,589.80 | 20,051,240.20 | 8,710,362.31 |
| 其他主营业务(元) | - | - | - | -386,109.35 |
| 其他业务(元) | - | - | - | -33,504.00 |
| 其他(元) | 349,930.41 | 314,462.22 | -931,056.75 | -386,109.35 |
| 毛利率(%) | ||||
| 黄芪生脉饮(%) | 43.76 | 50.84 | 56.39 | 59.39 |
| 伸筋丹胶囊(%) | 38.85 | 38.72 | 39.21 | 37.43 |
| 西洋参口服液(%) | 36.82 | 37.58 | 42.93 | 41.80 |
| 其他主营业务(%) | - | - | - | -14.95 |
| 其他业务(%) | - | - | - | -61.09 |
| 其他(%) | 4.37 | 6.70 | -13.18 | -14.95 |
| 收入构成(%) | ||||
| 黄芪生脉饮(%) | 76.12 | 77.38 | 77.04 | 77.69 |
| 伸筋丹胶囊(%) | 8.48 | 7.53 | 7.66 | 7.25 |
| 西洋参口服液(%) | 12.43 | 11.94 | 13.29 | 12.04 |
| 其他主营业务(%) | - | - | - | 1.49 |
| 其他业务(%) | - | - | - | 0.03 |
| 其他(%) | 2.96 | 3.15 | 2.01 | 1.49 |
| 毛利构成(%) | ||||
| 黄芪生脉饮(%) | 80.62 | 83.79 | 83.73 | 86.37 |
| 伸筋丹胶囊(%) | 7.98 | 6.21 | 5.79 | 5.08 |
| 西洋参口服液(%) | 11.08 | 9.56 | 11.00 | 9.42 |
| 其他主营业务(%) | - | - | - | -0.42 |
| 其他业务(%) | - | - | - | -0.04 |
| 其他(%) | 0.31 | 0.45 | -0.51 | -0.42 |